Phase II clinical trial of sequential non-randomized uncontrolled, multicenter Everolimus treatment of classic Kaposi's sarcoma or endemic [therapeutique de phase II sequentiel non randomise non controle, multicentrique de traitement par everolimus de la maladie de Kaposi classique ou endemique.]

Trial Profile

Phase II clinical trial of sequential non-randomized uncontrolled, multicenter Everolimus treatment of classic Kaposi's sarcoma or endemic [therapeutique de phase II sequentiel non randomise non controle, multicentrique de traitement par everolimus de la maladie de Kaposi classique ou endemique.]

Recruiting
Phase of Trial: Phase II

Latest Information Update: 29 Aug 2011

At a glance

  • Drugs Everolimus (Primary)
  • Indications Kaposi's sarcoma
  • Focus Therapeutic Use
  • Acronyms Rad Kaposi
  • Most Recent Events

    • 29 Aug 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top